nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.518	1	CbGbCtD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.0171	0.138	CbGpPWpGaD
Mitotane—FDX1—respiratory system—chronic obstructive pulmonary disease	0.0101	0.223	CbGeAlD
Mitotane—FDX1—bronchus—chronic obstructive pulmonary disease	0.00828	0.184	CbGeAlD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00814	0.0656	CbGpPWpGaD
Mitotane—FDX1—trachea—chronic obstructive pulmonary disease	0.00744	0.165	CbGeAlD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00611	0.0492	CbGpPWpGaD
Mitotane—FDX1—lung—chronic obstructive pulmonary disease	0.00534	0.119	CbGeAlD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00523	0.0421	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00483	0.0389	CbGpPWpGaD
Mitotane—SERPINA6—respiratory system—chronic obstructive pulmonary disease	0.00435	0.0966	CbGeAlD
Mitotane—CYP11A1—connective tissue—chronic obstructive pulmonary disease	0.00402	0.0894	CbGeAlD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00391	0.0315	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00351	0.0282	CbGpPWpGaD
Mitotane—SHBG—connective tissue—chronic obstructive pulmonary disease	0.00323	0.0716	CbGeAlD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00284	0.0229	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00276	0.0223	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0025	0.0201	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00247	0.0199	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00237	0.0191	CbGpPWpGaD
Mitotane—SERPINA6—lung—chronic obstructive pulmonary disease	0.00231	0.0513	CbGeAlD
Mitotane—FDX1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00208	0.0167	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00199	0.016	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00176	0.0142	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00176	0.0142	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00173	0.014	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00172	0.0139	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.0017	0.0137	CbGpPWpGaD
Mitotane—Mazindol—SLC6A4—chronic obstructive pulmonary disease	0.00168	0.644	CrCbGaD
Mitotane—FDX1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00159	0.0128	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00151	0.0122	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.0015	0.0121	CbGpPWpGaD
Mitotane—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00475	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00147	0.0118	CbGpPWpGaD
Mitotane—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00469	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00145	0.0117	CbGpPWpGaD
Mitotane—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00466	CcSEcCtD
Mitotane—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00465	CcSEcCtD
Mitotane—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00462	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00139	0.0112	CbGpPWpGaD
Mitotane—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00445	CcSEcCtD
Mitotane—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00439	CcSEcCtD
Mitotane—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00421	CcSEcCtD
Mitotane—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00418	CcSEcCtD
Mitotane—Hypothyroidism—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00417	CcSEcCtD
Mitotane—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00417	CcSEcCtD
Mitotane—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00416	CcSEcCtD
Mitotane—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00416	CcSEcCtD
Mitotane—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00415	CcSEcCtD
Mitotane—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00413	CcSEcCtD
Mitotane—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.00127	0.00409	CcSEcCtD
Mitotane—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00408	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00125	0.0101	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00123	0.00993	CbGpPWpGaD
Mitotane—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00396	CcSEcCtD
Mitotane—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00394	CcSEcCtD
Mitotane—FDX1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00121	0.00979	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00119	0.00961	CbGpPWpGaD
Mitotane—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00384	CcSEcCtD
Mitotane—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00373	CcSEcCtD
Mitotane—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00373	CcSEcCtD
Mitotane—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00373	CcSEcCtD
Mitotane—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00371	CcSEcCtD
Mitotane—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00369	CcSEcCtD
Mitotane—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00366	CcSEcCtD
Mitotane—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00363	CcSEcCtD
Mitotane—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00363	CcSEcCtD
Mitotane—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00362	CcSEcCtD
Mitotane—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0036	CcSEcCtD
Mitotane—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00353	CcSEcCtD
Mitotane—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00353	CcSEcCtD
Mitotane—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00348	CcSEcCtD
Mitotane—Fungal infection—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00347	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.00861	CbGpPWpGaD
Mitotane—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00343	CcSEcCtD
Mitotane—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00343	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00105	0.0085	CbGpPWpGaD
Mitotane—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00338	CcSEcCtD
Mitotane—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00338	CcSEcCtD
Mitotane—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00336	CcSEcCtD
Mitotane—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00336	CcSEcCtD
Mitotane—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00335	CcSEcCtD
Mitotane—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00335	CcSEcCtD
Mitotane—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00335	CcSEcCtD
Mitotane—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00331	CcSEcCtD
Mitotane—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00329	CcSEcCtD
Mitotane—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00329	CcSEcCtD
Mitotane—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00329	CcSEcCtD
Mitotane—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00328	CcSEcCtD
Mitotane—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00327	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00101	0.00816	CbGpPWpGaD
Mitotane—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.001	0.00323	CcSEcCtD
Mitotane—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000988	0.00319	CcSEcCtD
Mitotane—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000987	0.00318	CcSEcCtD
Mitotane—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00317	CcSEcCtD
Mitotane—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000983	0.00317	CcSEcCtD
Mitotane—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000981	0.00316	CcSEcCtD
Mitotane—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00316	CcSEcCtD
Mitotane—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000973	0.00314	CcSEcCtD
Mitotane—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00097	0.00313	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000966	0.00312	CcSEcCtD
Mitotane—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000943	0.00304	CcSEcCtD
Mitotane—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000943	0.00304	CcSEcCtD
Mitotane—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000935	0.00302	CcSEcCtD
Mitotane—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.00301	CcSEcCtD
Mitotane—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000929	0.003	CcSEcCtD
Mitotane—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000929	0.356	CrCbGaD
Mitotane—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.003	CcSEcCtD
Mitotane—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000928	0.00299	CcSEcCtD
Mitotane—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000928	0.00299	CcSEcCtD
Mitotane—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000927	0.00299	CcSEcCtD
Mitotane—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000924	0.00298	CcSEcCtD
Mitotane—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00298	CcSEcCtD
Mitotane—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00298	CcSEcCtD
Mitotane—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000918	0.00296	CcSEcCtD
Mitotane—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000915	0.00295	CcSEcCtD
Mitotane—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000909	0.00293	CcSEcCtD
Mitotane—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.00293	CcSEcCtD
Mitotane—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000906	0.00292	CcSEcCtD
Mitotane—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000903	0.00291	CcSEcCtD
Mitotane—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000903	0.00291	CcSEcCtD
Mitotane—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000902	0.00291	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000891	0.00718	CbGpPWpGaD
Mitotane—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000881	0.00284	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00088	0.00709	CbGpPWpGaD
Mitotane—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000878	0.00283	CcSEcCtD
Mitotane—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000876	0.00283	CcSEcCtD
Mitotane—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000872	0.00281	CcSEcCtD
Mitotane—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.00281	CcSEcCtD
Mitotane—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000871	0.00281	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000866	0.00698	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000866	0.00698	CbGpPWpGaD
Mitotane—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000864	0.00279	CcSEcCtD
Mitotane—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000864	0.00279	CcSEcCtD
Mitotane—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00086	0.00277	CcSEcCtD
Mitotane—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00275	CcSEcCtD
Mitotane—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000846	0.00273	CcSEcCtD
Mitotane—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000838	0.0027	CcSEcCtD
Mitotane—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000829	0.00268	CcSEcCtD
Mitotane—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000821	0.00265	CcSEcCtD
Mitotane—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.00263	CcSEcCtD
Mitotane—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000805	0.0026	CcSEcCtD
Mitotane—FDX1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000805	0.00648	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000798	0.00643	CbGpPWpGaD
Mitotane—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000796	0.00257	CcSEcCtD
Mitotane—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.00257	CcSEcCtD
Mitotane—FDX1—Metabolism—GC—chronic obstructive pulmonary disease	0.000783	0.00631	CbGpPWpGaD
Mitotane—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.00252	CcSEcCtD
Mitotane—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000782	0.00252	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00078	0.00252	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00078	0.00252	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000764	0.00246	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000762	0.00614	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000754	0.00608	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000753	0.00607	CbGpPWpGaD
Mitotane—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00243	CcSEcCtD
Mitotane—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000748	0.00241	CcSEcCtD
Mitotane—Infection—Formoterol—chronic obstructive pulmonary disease	0.000748	0.00241	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00074	0.00596	CbGpPWpGaD
Mitotane—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00238	CcSEcCtD
Mitotane—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00238	CcSEcCtD
Mitotane—Infection—Montelukast—chronic obstructive pulmonary disease	0.000732	0.00236	CcSEcCtD
Mitotane—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000732	0.00236	CcSEcCtD
Mitotane—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000731	0.00236	CcSEcCtD
Mitotane—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000731	0.00236	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00073	0.00588	CbGpPWpGaD
Mitotane—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000729	0.00235	CcSEcCtD
Mitotane—FDX1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000728	0.00586	CbGpPWpGaD
Mitotane—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000723	0.00233	CcSEcCtD
Mitotane—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000722	0.00233	CcSEcCtD
Mitotane—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000716	0.00231	CcSEcCtD
Mitotane—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00228	CcSEcCtD
Mitotane—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.00227	CcSEcCtD
Mitotane—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000703	0.00227	CcSEcCtD
Mitotane—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.00226	CcSEcCtD
Mitotane—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00225	CcSEcCtD
Mitotane—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00069	0.00223	CcSEcCtD
Mitotane—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000687	0.00222	CcSEcCtD
Mitotane—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00219	CcSEcCtD
Mitotane—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000677	0.00218	CcSEcCtD
Mitotane—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00216	CcSEcCtD
Mitotane—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00216	CcSEcCtD
Mitotane—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00214	CcSEcCtD
Mitotane—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000663	0.00214	CcSEcCtD
Mitotane—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000663	0.00214	CcSEcCtD
Mitotane—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00214	CcSEcCtD
Mitotane—Injury—Prednisone—chronic obstructive pulmonary disease	0.000656	0.00212	CcSEcCtD
Mitotane—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000655	0.00211	CcSEcCtD
Mitotane—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000654	0.00211	CcSEcCtD
Mitotane—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00065	0.0021	CcSEcCtD
Mitotane—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00065	0.0021	CcSEcCtD
Mitotane—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000649	0.00209	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000645	0.0052	CbGpPWpGaD
Mitotane—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00208	CcSEcCtD
Mitotane—Pain—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00208	CcSEcCtD
Mitotane—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00207	CcSEcCtD
Mitotane—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00206	CcSEcCtD
Mitotane—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00205	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000633	0.0051	CbGpPWpGaD
Mitotane—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00204	CcSEcCtD
Mitotane—Pain—Montelukast—chronic obstructive pulmonary disease	0.00063	0.00203	CcSEcCtD
Mitotane—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000629	0.00203	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000626	0.00504	CbGpPWpGaD
Mitotane—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000626	0.00202	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000625	0.00503	CbGpPWpGaD
Mitotane—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000624	0.00201	CcSEcCtD
Mitotane—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00201	CcSEcCtD
Mitotane—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00062	0.002	CcSEcCtD
Mitotane—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.002	CcSEcCtD
Mitotane—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00062	0.002	CcSEcCtD
Mitotane—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00199	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000617	0.00497	CbGpPWpGaD
Mitotane—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000617	0.00199	CcSEcCtD
Mitotane—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000615	0.00198	CcSEcCtD
Mitotane—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00198	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000609	0.00491	CbGpPWpGaD
Mitotane—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00196	CcSEcCtD
Mitotane—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00194	CcSEcCtD
Mitotane—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.00192	CcSEcCtD
Mitotane—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000595	0.00192	CcSEcCtD
Mitotane—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000593	0.00191	CcSEcCtD
Mitotane—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.0019	CcSEcCtD
Mitotane—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.0019	CcSEcCtD
Mitotane—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000587	0.0019	CcSEcCtD
Mitotane—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00189	CcSEcCtD
Mitotane—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.00189	CcSEcCtD
Mitotane—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00188	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00058	0.00467	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000577	0.00465	CbGpPWpGaD
Mitotane—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000575	0.00186	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000567	0.00457	CbGpPWpGaD
Mitotane—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00181	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00056	0.00451	CbGpPWpGaD
Mitotane—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000555	0.00179	CcSEcCtD
Mitotane—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000555	0.00179	CcSEcCtD
Mitotane—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000554	0.00179	CcSEcCtD
Mitotane—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000553	0.00178	CcSEcCtD
Mitotane—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000543	0.00175	CcSEcCtD
Mitotane—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00174	CcSEcCtD
Mitotane—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00174	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000538	0.00433	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000536	0.00432	CbGpPWpGaD
Mitotane—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00172	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00053	0.00427	CbGpPWpGaD
Mitotane—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00171	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000528	0.00426	CbGpPWpGaD
Mitotane—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000524	0.00169	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000521	0.0042	CbGpPWpGaD
Mitotane—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00166	CcSEcCtD
Mitotane—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00166	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000512	0.00412	CbGpPWpGaD
Mitotane—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00165	CcSEcCtD
Mitotane—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00163	CcSEcCtD
Mitotane—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000498	0.00161	CcSEcCtD
Mitotane—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000498	0.00161	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000494	0.00398	CbGpPWpGaD
Mitotane—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000488	0.00157	CcSEcCtD
Mitotane—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000487	0.00157	CcSEcCtD
Mitotane—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00157	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000485	0.00391	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000479	0.00386	CbGpPWpGaD
Mitotane—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00154	CcSEcCtD
Mitotane—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00154	CcSEcCtD
Mitotane—Rash—Formoterol—chronic obstructive pulmonary disease	0.000475	0.00153	CcSEcCtD
Mitotane—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.00153	CcSEcCtD
Mitotane—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00153	CcSEcCtD
Mitotane—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00153	CcSEcCtD
Mitotane—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00152	CcSEcCtD
Mitotane—Headache—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00152	CcSEcCtD
Mitotane—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000471	0.00152	CcSEcCtD
Mitotane—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00152	CcSEcCtD
Mitotane—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00151	CcSEcCtD
Mitotane—Rash—Montelukast—chronic obstructive pulmonary disease	0.000465	0.0015	CcSEcCtD
Mitotane—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000464	0.0015	CcSEcCtD
Mitotane—Headache—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00149	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00046	0.00371	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000454	0.00366	CbGpPWpGaD
Mitotane—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00146	CcSEcCtD
Mitotane—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00145	CcSEcCtD
Mitotane—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00145	CcSEcCtD
Mitotane—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00144	CcSEcCtD
Mitotane—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00144	CcSEcCtD
Mitotane—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00144	CcSEcCtD
Mitotane—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00144	CcSEcCtD
Mitotane—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00141	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000438	0.00353	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000433	0.00349	CbGpPWpGaD
Mitotane—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000431	0.00139	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000428	0.00345	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000423	0.00341	CbGpPWpGaD
Mitotane—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00136	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00041	0.00132	CcSEcCtD
Mitotane—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000401	0.00129	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000394	0.00318	CbGpPWpGaD
Mitotane—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00126	CcSEcCtD
Mitotane—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00125	CcSEcCtD
Mitotane—FDX1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000386	0.00311	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000381	0.00307	CbGpPWpGaD
Mitotane—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00122	CcSEcCtD
Mitotane—CYP11A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00037	0.00298	CbGpPWpGaD
Mitotane—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.00118	CcSEcCtD
Mitotane—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00118	CcSEcCtD
Mitotane—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00117	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.00286	CbGpPWpGaD
Mitotane—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00112	CcSEcCtD
Mitotane—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000342	0.0011	CcSEcCtD
Mitotane—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.00108	CcSEcCtD
Mitotane—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00108	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000326	0.00263	CbGpPWpGaD
Mitotane—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00105	CcSEcCtD
Mitotane—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00101	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000309	0.00249	CbGpPWpGaD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00099	CcSEcCtD
Mitotane—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000969	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000296	0.00239	CbGpPWpGaD
Mitotane—Infection—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00095	CcSEcCtD
Mitotane—FDX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000292	0.00236	CbGpPWpGaD
Mitotane—Shock—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00094	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000937	CcSEcCtD
Mitotane—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000928	CcSEcCtD
Mitotane—CYP11B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000287	0.00231	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00229	CbGpPWpGaD
Mitotane—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000911	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000279	0.00225	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000272	0.00219	CbGpPWpGaD
Mitotane—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00087	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000858	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000264	0.00213	CbGpPWpGaD
Mitotane—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000841	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000259	0.00209	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000258	0.00208	CbGpPWpGaD
Mitotane—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000831	CcSEcCtD
Mitotane—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.000829	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.000829	CcSEcCtD
Mitotane—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000824	CcSEcCtD
Mitotane—CYP11A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000245	0.00198	CbGpPWpGaD
Mitotane—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000788	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.00196	CbGpPWpGaD
Mitotane—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000781	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000239	0.00192	CbGpPWpGaD
Mitotane—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000756	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000222	0.00179	CbGpPWpGaD
Mitotane—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000704	CcSEcCtD
Mitotane—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000686	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000207	0.00166	CbGpPWpGaD
Mitotane—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000654	CcSEcCtD
Mitotane—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000632	CcSEcCtD
Mitotane—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000608	CcSEcCtD
Mitotane—Rash—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000603	CcSEcCtD
Mitotane—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000602	CcSEcCtD
Mitotane—Headache—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000599	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00142	CbGpPWpGaD
Mitotane—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000568	CcSEcCtD
Mitotane—FDX1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000176	0.00141	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000168	0.00135	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000152	0.00123	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000151	0.00121	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00014	0.00113	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000137	0.00111	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00013	0.00105	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000129	0.00104	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00102	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00012	0.000968	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000118	0.000947	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.000873	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000106	0.000851	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000104	0.000839	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.7e-05	0.000782	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.2e-05	0.000741	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.03e-05	0.000728	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.91e-05	0.000718	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.3e-05	0.000669	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.87e-05	0.000634	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—chronic obstructive pulmonary disease	6.25e-05	0.000504	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.98e-05	0.000482	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.35e-05	0.000431	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.12e-05	0.000412	CbGpPWpGaD
